A Review of Next-Generation Therapeutics and Contemporary Management of Myelofibrosis

Download this slideset from a live symposium at ASH 2022 to review diagnostic considerations with MPNs and risk stratification for patients with MF.

Brady L. Stein, MD, MHS Released: December 9, 2022

Download this slideset from a live symposium at ASH 2022 to review current best practices and emerging strategies for treating patients who are newly diagnosed with myelofibrosis.

Srdan Verstovsek, MD, PhD
Program Director Released: December 9, 2022

Download this slideset from a live symposium at ASH 2022 to review current best practices and emerging strategies for treating patients with myelofibrosis who have received previous therapies (including ruxolitinib).

Abdulraheem Yacoub, MD Released: December 9, 2022

Download this short summary slideset of key takeaway points from a live presentation on current best practices and emerging strategies in managing patients with MF.

Srdan Verstovsek, MD, PhD
Program Director Brady L. Stein, MD, MHS Abdulraheem Yacoub, MD Released: December 16, 2022

Watch this on-demand webcast from an ASH satellite symposium on the use of current and emerging therapies for patients with myelofibrosis, including discussions on individualized treatment plans, treatment for relapsed/refractory disease, managing treatment-related toxicities, and clinical trials.

Srdan Verstovsek, MD, PhD
Program Director Brady L. Stein, MD, MHS Abdulraheem Yacoub, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Released: December 20, 2022 Expired: December 19, 2023